Kirk Sperber
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
- Virology 27
- HIV Research and Treatment 25
- Immunology 27
- Immune Cell Function and Interaction 15
- Immune Response and Inflammation 7
- Co-authors
- Johan R. Boelaert (6 shared papers)Vera J. Stecher (4 shared papers)Thomas Kalb (8 shared papers)Lloyd Mayer (13 shared papers)Andrea Savarino (3 shared papers)Larry D. Altstiel (1 shared paper)Luisa Gennero (5 shared papers)Julia Ash (7 shared papers)
- Journals
- Journal of Allergy and Clinical Immunology (6 papers)The Journal of Immunology (4 papers)Gastroenterology (4 papers)Cardiology in Review (4 papers)Clinical Therapeutics (3 papers)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Kirk Sperber
80 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 117
- Virology 448
- Infectious Diseases 619
- Immunology 605
- Immunology and Allergy 122
- Rheumatology 294
Countries citing papers authored by Kirk Sperber
This map shows the geographic impact of Kirk Sperber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Sperber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Sperber more than expected).
Fields of papers citing papers by Kirk Sperber
This network shows the impact of papers produced by Kirk Sperber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Sperber. The network helps show where Kirk Sperber may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirk Sperber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. | 1993 | 154 |
| 2 | 1995 | 127 | |
| 3 | 2001 | 96 | |
| 4 | 1993 | 94 | |
| 5 | 2009 | 93 | |
| 6 | 2001 | 91 | |
| 7 | 2004 | 90 | |
| 8 | 1991 | 88 | |
| 9 | 1996 | 86 | |
| 10 | 1997 | 80 | |
| 11 | 2006 | 73 | |
| 12 | 1999 | 71 | |
| 13 | 1996 | 69 | |
| 14 | 2011 | 68 | |
| 15 | 1997 | 66 | |
| 16 | 1996 | 60 | |
| 17 | 1992 | 60 | |
| 18 | 2001 | 56 | |
| 19 | 1999 | 51 | |
| 20 | 1995 | 41 |
About Kirk Sperber
Kirk Sperber is a scholar working on Virology, Immunology, Epidemiology, Infectious Diseases and Molecular Biology, having authored 82 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (25 papers), Immune Cell Function and Interaction (15 papers), HIV/AIDS drug development and treatment (12 papers), Asthma and respiratory diseases (7 papers), Immune Response and Inflammation (7 papers), Systemic Lupus Erythematosus Research (6 papers), Glycosylation and Glycoproteins Research (5 papers) and HIV/AIDS Research and Interventions (4 papers). The work is most often cited by research in Virology (448 citations), Infectious Diseases (619 citations), Immunology (605 citations), Immunology and Allergy (122 citations) and Rheumatology (294 citations). Kirk Sperber has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Johan R. Boelaert, Vera J. Stecher, Thomas Kalb, Lloyd Mayer, Andrea Savarino, Larry D. Altstiel, Luisa Gennero, Julia Ash, Michael J. Louie and Deborah L. Shapiro. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Immunology, Gastroenterology, Cardiology in Review and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.